A comprehensive cardiovascular risk panel is offered that analyzes genetic mutations that may increase the risk of cardiovascular disease. The test provides information about hereditary thrombophilia factors and genetic predispositions affecting cardiovascular health.
Mutations Included in the Panel
- Factor II Prothrombin (G20210A)
- Factor V (G1691A, H1299R)
- MTHFR (C677T, A1298C)
- Factor XIII (V34L)
- β-Fibrinogen (-455 G-A)
- PAI-1 (4G/5G)
- HPA-1 (a/b)
- ACE (I/D)
- ApoB (R3500Q)
- ApoE (e2/e3/e4)
These tests help evaluate the genetic factors associated with cardiovascular risk and enable personalized strategies for the prevention and management of cardiovascular disease.